Clinical and Laboratory Diagnosis for Naegleria fowleri Infection

For Health Care Providers

What to know

  • Primary amebic meningoencephalitis (PAM) is a rare but nearly always fatal brain infection caused by the ameba Naegleria fowleri.
  • PAM is diagnosed using laboratory tests.
  • The tests are available in only a few laboratories in the United States, including CDC.
High resolution of Naegleria fowleri ameba in a person's cerebrospinal fluid

Diagnosing Naegleria fowleri infection

Clinicians

For 24/7 diagnostic assistance, specimen collection guidance, shipping instructions, and treatment recommendations, contact the CDC Emergency Operations Center at 770-488-7100.

PAM is diagnosed by detecting Naegleria fowleri amebas using different tests offered by only a few U.S. laboratories, including CDC. The tests include:

  • A polymerase chain reaction (PCR) test that detects Naegleria fowleri in a patient's cerebrospinal fluid (CSF) or tissue
  • Immunohistochemical (IHC) testing and indirect immunofluorescent (IIF) staining that use specific antibodies against Naegleria fowleri to detect the ameba
  • Direct visualization by examining CSF under a microscope. Naegleria fowleri can be identified in CSF smears or cultures using hematoxylin and eosin (H&E), periodic acid-Schiff (PAS), trichrome, Giemsa, or Wright-Giemsa stains. Note: A Gram stain should be avoided since Naegleria fowleri can be destroyed during heat fixation.
High resolution of a person's cerebrospinal fluid. Two arrows point to Naegleria fowleri amebas
Only a few U.S. laboratories, including CDC, can test for Naegleria fowleri amebas in a patient's cerebral spinal fluid, as shown in this image. Photos: Dr. James Roberts, Children's Healthcare of Atlanta

CDC offers diagnostic assistance for Naegleria fowleri infection to physicians and scientists through DPDx and the Free-Living and Intestinal Amebas (FLIA) Lab.

Morphology experts at DPDx can evaluate microscopic images. Scientists at the FLIA laboratory provide diagnostic assistance using molecular and immunofluorescence assays.

Content Source
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
About this page
Published: May 15, 2024
Updated: April 15, 2024

This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.

Reviewed: November 16, 2026

The information on this page was last reviewed by subject matter experts to ensure accuracy.